U.S. flag

An official website of the United States government

nsv934328

  • Variant Calls:2
  • Validation:Yes
  • Clinical Assertions: No
  • Region Size:76,991

Links to Other Resources

Genome View

Select assembly:
Overlapping variant regions from other studies: 238 SVs from 47 studies. See in: genome view    
Remapped(Score: Perfect):88,943,686-89,020,676Question Mark
Overlapping variant regions from other studies: 238 SVs from 47 studies. See in: genome view    
Remapped(Score: Perfect):88,676,854-88,753,844Question Mark
Overlapping variant regions from other studies: 62 SVs from 17 studies. See in: genome view    
Submitted genomic88,316,502-88,393,492Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeScoreAssemblyAssembly UnitReciprocitySequence IDChrOuter StartInner StartInner StopOuter Stop
nsv934328RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000011.10Chr1188,943,68688,963,49489,014,37989,020,676
nsv934328RemappedPerfectGRCh37.p13Primary AssemblyFirst PassNC_000011.9Chr1188,676,85488,696,66288,747,54788,753,844
nsv934328Submitted genomicNCBI36 (hg18)Primary AssemblyNC_000011.8Chr1188,316,50288,336,31088,387,19588,393,492

Variant Call Information

Variant Call IDTypeMethodAnalysisSubject PhenotypeCopy numberZygosity
nssv1660666copy number gainSNP arraySNP genotyping analysisNASOPHARYNGEAL CARCINOMA; NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2; NPCA23Heterozygous
nssv1660667copy number gainSNP arraySNP genotyping analysisNASOPHARYNGEAL CARCINOMA; NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2; NPCA23Heterozygous

Variant Call Placement Information

Variant Call IDPlacement TypeScoreHGVSAssemblyReciprocitySequence IDChrOuter StartInner StartInner StopOuter Stop
nssv1660666RemappedPerfectNC_000011.10:g.(88
943686_88963494)_(
89011257_89014380)
dup
GRCh38.p12First PassNC_000011.10Chr1188,943,68688,963,49489,011,25789,014,380
nssv1660667RemappedPerfectNC_000011.10:g.(88
943686_88963494)_(
89014380_89020676)
dup
GRCh38.p12First PassNC_000011.10Chr1188,943,68688,963,49489,014,38089,020,676
nssv1660666RemappedPerfectNC_000011.9:g.(886
76854_88696662)_(8
8744425_88747548)d
up
GRCh37.p13First PassNC_000011.9Chr1188,676,85488,696,66288,744,42588,747,548
nssv1660667RemappedPerfectNC_000011.9:g.(886
76854_88696662)_(8
8747548_88753844)d
up
GRCh37.p13First PassNC_000011.9Chr1188,676,85488,696,66288,747,54888,753,844
nssv1660666Submitted genomicNC_000011.8:g.(883
16502_88336310)_(8
8384073_88387196)d
up
NCBI36 (hg18)NC_000011.8Chr1188,316,50288,336,31088,384,07388,387,196
nssv1660667Submitted genomicNC_000011.8:g.(883
16502_88336310)_(8
8387196_88393492)d
up
NCBI36 (hg18)NC_000011.8Chr1188,316,50288,336,31088,387,19688,393,492

Validation Information

Variant Call IDExperiment IDMethodAnalysisResult
nssv16606662qPCRProbe signal intensityPass
nssv16606672qPCRProbe signal intensityPass

No clinical assertion data were submitted for this variant

No genotype data were submitted for this variant

Support Center